EUVIMEDEUVIMED entdecken
Crossref

Diagnostic role and prognostic value of tumor markers in high-grade gastro-enteropancreatic neuroendocrine neoplasms

Changhao Gao, Zhiyao Fan, Jian Yang, Ming Shi, Yongzheng Li, Hanxiang Zhan

Pancreatology · 2023

DOI: 10.1016/j.pan.2023.01.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pancreatology, 2023. Verfasst von Changhao Gao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pancreatic Surgery, Department of General Surgery, Qilu Hospital, Shandong University, Jinan, Shandong Province, China. Hauptthemen laut MEDLINE: Intestinal Neoplasms, Stomach Neoplasms, Pancreatic Neoplasms, Neuroendocrine Tumors. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: High-grade gastro-enteropancreatic neuroendocrine neoplasms (GEP-NENs) are a heterogeneous group of rare tumors of two different types: well differentiated neuroendocrine tumors grade 3 (NETs G3) and poorly differentiated neuroendocrine carcinomas (NECs). This study aimed to explore the value of eight common preoperative markers in differentiating NETs G3 from NECs and the prognosis prediction of high-grade GEP-NENs. METHODS: Seventy-two patients diagnosed with high-grade GEP-NENs who underwent surgery at our institution were recruited for this study. Demographic and clinicopathological characteristics, preoperative serum tumor markers, and survival data were collected and analyzed. Kaplan-Meier methods were used to analyze survival rates, and a Cox regression model was used to perform multivariate analyses. RESULTS: Serum carcinoembryonic antigen (CEA) was dramatically higher in NECs than in NETs G3 (P = 0.025). After follow-up, 57 of the 72 patients remained for survival analysis. Elevated serum carbohydrate antigen 19-9 (CA19-9), CEA, cancer antigen 125 and sialic acid (SA) levels indicated poorer survival of high-grade GEP-NEN patients. Only CA19-9 (HR: 6.901, 95% CI: 1.843 to 25.837, P = 0.004) was regarded as an independent risk factor for overall survival. Serum CA19-9 (HR: 4.689, 95% CI: 1.127 to 19.506, P = 0.034) was also regarded as an independent factor for overall survival in NECs. CONCLUSIONS: Serum CEA levels can be used to distinguish NETs G3 from NECs. Preoperative CA19-9, CEA, cancer antigen 125 and SA levels have predictive value in the prognosis of high-grade GEP-NENs. Preoperative CA19-9, neuron-specific enolase, and SA levels can predict the prognosis of NECs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intestinal NeoplasmsStomach NeoplasmsPancreatic NeoplasmsNeuroendocrine TumorsCarcinoma, NeuroendocrineHumansPrognosisBiomarkers, TumorCA-19-9 AntigenCA-125 AntigenCarcinoembryonic Antigen

Stichwörter der Autor:innen

Carbohydrate antigen 19-9Carcinoembryonic antigenGastro-enteropancreatic neuroendocrine neoplasmOverall survivalTumor marker

Substanzen

Biomarkers, TumorCA-19-9 AntigenCA-125 AntigenCarcinoembryonic Antigen

Autor:innen und Institutionen

  • Division of Pancreatic Surgery, Department of General Surgery, Qilu Hospital, Shandong University, Jinan, Shandong Province, China.
  • Division of Pancreatic Surgery, Department of General Surgery, Qilu Hospital, Shandong University, Jinan, Shandong Province, China. Electronic address: zhanhanxiang@hotmail.com.

Zitieren

APA

Gao, C., Fan, Z., Yang, J., Shi, M., Li, Y., & Zhan, H. (2023). Diagnostic role and prognostic value of tumor markers in high-grade gastro-enteropancreatic neuroendocrine neoplasms. Pancreatology. https://doi.org/10.1016/j.pan.2023.01.009

Vancouver

Gao C, Fan Z, Yang J, Shi M, Li Y, Zhan H. Diagnostic role and prognostic value of tumor markers in high-grade gastro-enteropancreatic neuroendocrine neoplasms. Pancreatology. 2023. doi:10.1016/j.pan.2023.01.009

BibTeX
@article{Gao2023,
  author = {Gao, Changhao and Fan, Zhiyao and Yang, Jian and Shi, Ming and Li, Yongzheng and Zhan, Hanxiang},
  title = {Diagnostic role and prognostic value of tumor markers in high-grade gastro-enteropancreatic neuroendocrine neoplasms},
  journal = {Pancreatology},
  year = {2023},
  doi = {10.1016/j.pan.2023.01.009}
}
Kostenlos starten →